Name | ABC44 |
---|---|
Synonyms |
ABC44
Imidazo[1,5-a]pyrazine-1,3(2H,5H)-dione, tetrahydro-2-[[[4-(4-methoxyphenyl)-1-piperazinyl]carbonyl]oxy]-7-[[1-(phenylmethyl)-4-piperidinyl]methyl]- 7-[(1-Benzyl-4-piperidinyl)methyl]-2-({[4-(4-methoxyphenyl)-1-piperazinyl]carbonyl}oxy)tetrahydroimidazo[1,5-a]pyrazine-1,3(2H,5H)-dione 7-((1-Benzylpiperidin-4-yl)methyl)-1,3-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl 4-(4-methoxyphenyl)piperazine-1-carboxylate 4-(4-Methoxyphenyl)-1-piperazinecarboxylic acid hexahydro-1,3-dioxo-7-[[1-(phenylmethyl)-4-piperidinyl]methyl]imidazo[1,5-a]pyrazin-2-yl ester |
Description | ABC44 is a potent serine hydrolase inhibitor with IC50s of 0.1 μM and 6.5 μM for palmitoyl protein thioesterase 1 (PPT1) in situ and in vitro, respectively. ABC44 can be used for researching infantile neuronal ceroid lipofuscinosis[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.1 μM (PPT1 in situ), 6.5 μM (PPT1 in vitro)[1] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 689.8±65.0 °C at 760 mmHg |
Molecular Formula | C31H40N6O5 |
Molecular Weight | 576.687 |
Flash Point | 371.0±34.3 °C |
Exact Mass | 576.306030 |
LogP | 1.75 |
Vapour Pressure | 0.0±2.2 mmHg at 25°C |
Index of Refraction | 1.669 |